{"": [138, 147, 0, 148, 1521, 0], "Introduction": [1522, 6069, 0], "Cells and viruses": [6093, 7477, 0], "Vaccine lots": [7478, 8165, 0], "SDS-PAGE": [8994, 9361, 0], "Visualization of inactivated viral particles with transmission electron microscopy (TEM)": [8166, 9361, 1], "Western blot": [9362, 10294, 0], "ELISA": [11320, 11605, 0], "Infection and immunostaining of Vero cells": [10295, 11605, 1], "Virus neutralization test (NT)": [11606, 12423, 0], "Ethical approval": [12424, 12992, 0], "Animal models for safety studies": [12993, 15950, 0], "Protective efficacy study in Syrian hamsters": [15951, 17109, 0, 39337, 43584, 0], "Histological examination": [17110, 18141, 0], "Blood analysis": [18142, 18492, 0], "Splenocyte proliferation assay": [18493, 20710, 0, 37609, 39336, 0], "Statistical analysis": [20711, 21444, 0], "Materials and methods": [6070, 21444, 1], "Vaccine production and description": [21454, 24020, 0], "Safety in mice and Guinea pigs": [24021, 28209, 0], "Safety in non-human primates (Callithrix jacchus)": [28210, 29111, 0], "Study of embryo-, fetotoxicity and teratogenic effects in the antenatal and postnatal periods of development": [29112, 31972, 0], "Study of reproductive toxicity": [31973, 34800, 0], "Immunogenicity in laboratory animals": [34801, 35853, 0], "Antibody specificity after immunization in BALB/c mice": [35854, 37608, 0], "Dose-dependence and durability of NAb response in mice and marmosets": [43585, 44818, 0], "Robustness of the manufacturing process of the vaccine covivac": [44819, 45732, 0], "Results": [21445, 45732, 1], "Characterization of the vaccine CoviVac": [46394, 47876, 0], "Safety": [47877, 48922, 0], "Immunity and its durability": [48923, 51254, 0], "Protective efficacy": [51255, 54149, 0], "Discussion": [45733, 54149, 1], "Supplementary Material": [54150, 54212, 0]}